BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyake Y, Iwasaki Y, Terada R, Takaguchi K, Sakaguchi K, Shiratori Y. Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. J Gastroenterol. 2007;42:485-492. [PMID: 17671764 DOI: 10.1007/s00535-007-2029-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Feng G, Zhao Y, Zhang J, Feng L, Yang J. Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study. BMJ Open 2015;5:e008033. [PMID: 26297362 DOI: 10.1136/bmjopen-2015-008033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
2 Szymczak M, Kaliciński P, Kowalewski G, Broniszczak D, Markiewicz-Kijewska M, Ismail H, Stefanowicz M, Kowalski A, Teisseyre J, Jankowska I, Patkowski W. Acute liver failure in children-Is living donor liver transplantation justified? PLoS One 2018;13:e0193327. [PMID: 29474400 DOI: 10.1371/journal.pone.0193327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Roth GA, Faybik P, Hetz H, Ankersmit HJ, Hoetzenecker K, Bacher A, Thalhammer T, Krenn CG. MCP-1 and MIP3-alpha serum levels in acute liver failure and molecular adsorbent recirculating system (MARS) treatment: a pilot study. Scand J Gastroenterol. 2009;44:745-751. [PMID: 19247846 DOI: 10.1080/00365520902770086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
4 Li H, Zhao XK, Cheng YJ, Zhang Q, Wu J, Lu S, Zhang W, Liu Y, Zhou MY, Wang Y, Yang J, Cheng ML. Gasdermin D-mediated hepatocyte pyroptosis expands inflammatory responses that aggravate acute liver failure by upregulating monocyte chemotactic protein 1/CC chemokine receptor-2 to recruit macrophages. World J Gastroenterol 2019; 25(44): 6527-6540 [PMID: 31802832 DOI: 10.3748/wjg.v25.i44.6527] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. Systematic review: acute liver failure - one disease, more than 40 definitions. Aliment Pharmacol Ther. 2012;35:1245-1256. [PMID: 22506515 DOI: 10.1111/j.1365-2036.2012.05097.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 7.8] [Reference Citation Analysis]
6 Liu Z, Li X, Qiu L, Zhang X, Chen L, Cao S, Wang F, Meng S. Treg suppress CTL responses upon immunization with HSP gp96. Eur J Immunol 2009;39:3110-20. [PMID: 19839010 DOI: 10.1002/eji.200939593] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
7 Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: A curable disease by 2024? J Hepatol. 2015;62:S112-S120. [PMID: 25920080 DOI: 10.1016/j.jhep.2014.12.016] [Cited by in Crossref: 130] [Cited by in F6Publishing: 108] [Article Influence: 26.0] [Reference Citation Analysis]
8 Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH. Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Liver Int 2011;31:499-506. [PMID: 21382160 DOI: 10.1111/j.1478-3231.2011.02450.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
9 Donnelly MC, Hayes PC, Simpson KJ. Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy. World J Gastroenterol 2016; 22(26): 5958-5970 [PMID: 27468190 DOI: 10.3748/wjg.v22.i26.5958] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
10 Roth G, Faybik P, Hetz H, Hacker S, Ankersmit H, Bacher A, Thalhammer T, Krenn C. Pro-inflammatory Interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment. Digestive and Liver Disease 2009;41:417-23. [DOI: 10.1016/j.dld.2008.09.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
11 Wu D, Wang H, Yan W, Chen T, Wang M, Han M, Wu Z, Wang X, Ai G, Xi D, Shen G, Luo X, Ning Q. A disparate subset of double-negative T cells contributes to the outcome of murine fulminant viral hepatitis via effector molecule fibrinogen-like protein 2. Immunol Res 2016;64:518-30. [PMID: 26482053 DOI: 10.1007/s12026-015-8727-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
12 Roth GA, Zimmermann M, Lubsczyk BA, Pilz J, Faybik P, Hetz H, Hacker S, Mangold A, Bacher A, Krenn CG. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J Surg Res. 2010;163:e79-e83. [PMID: 20638676 DOI: 10.1016/j.jss.2010.04.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
13 Wu D, Yan W, Wang H, Huang D, Luo X, Ning Q. γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ. CURR MED SCI 2018;38:648-55. [DOI: 10.1007/s11596-018-1926-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]